Hologic sells Lifecodes to Immucor for $85M

Immucor agrees to acquire Hologic's Lifecodes transplant diagnostics business in a deal worth up to $95 million, marking the 1st publicly reported acquisition by Immucor since former Medtronic CEO William Hawkins took the corner office.

In-vitro diagnostics maker Immucor [1] (NSDQ:BLUD [2]) signed a definitive agreement to acquire the Lifecodes transplant diagnostics business of Hologic [3] (NSDQ:HOLX [4]) in a deal worth up to $95 million.

Immucor paid $85 million in cash, with another $10 million to be paid out for certain financial milestones, according to a press release.

The Lifecodes business is a "worldwide leader in transplantation diagnostics," part of a $400 million global market that Immucor says is growing fast. Hologic acquired Lifecodes' technology in August 2012 when it acquired [5] molecular diagnostics giant Gen-Probe [6] (NSDQ:GPRO [7]) for $4 billion.